13209-45-5

• 

• Basic information

  1. Product Name: 4,6-estradiene-3,17-dione
  2. Synonyms: 4,6-estradiene-3,17-dione
  3. CAS NO:13209-45-5
  4. Molecular Formula: C₁₈H₂₂O₂
  5. Molecular Weight: 270.37
  6. EINECS: N/A
  7. Product Categories: N/A
  8. Mol File: 13209-45-5.mol
  9. Article Data: 8

• Chemical Properties

  1. Melting Point: N/A
  2. Boiling Point: 453.3°C at 760 mmHg
  3. Flash Point: 168.8°C
  4. Appearance: /
  5. Density: 1.15g/cm³
  6. Vapor Pressure: 2.1E-08mmHg at 25°C
  7. Refractive Index: 1.574
  8. Storage Temp.: N/A
  9. Solubility: N/A
  10. CAS DataBase Reference: 4,6-estradiene-3,17-dione(CAS DataBase Reference)
  11. NIST Chemistry Reference: 4,6-estradiene-3,17-dione(13209-45-5)
  12. EPA Substance Registry System: 4,6-estradiene-3,17-dione(13209-45-5)

• Safety Data

  1. Hazard Codes: N/A
  2. Statements: N/A
  3. Safety Statements: N/A
  4. WGK Germany:
  5. RTECS:
  6. HazardClass: N/A
  7. PackingGroup: N/A
  8. Hazardous Substances Data: 13209-45-5(Hazardous Substances Data)

• Suppliers
• Usage
• SDS
• Upstream product
• Downstream Products
• Article

13209-45-5 Suppliers

Recommended suppliersmore

• Product
• FOB Price
• Min.Order
• Supply Ability
• Supplier
• Contact Supplier

• 4,6-ESTRADIENE-3,17-DIONE

  Cas No: 13209-45-5

• No Data

• No Data

• No Data

• Hangzhou Fandachem Co.,Ltd
• Contact Supplier

• 4, 6-estradien-3, 17-dione

  Cas No: 13209-45-5

• No Data

• No Data

• No Data

• NovaChemistry
• Contact Supplier

13209-45-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 13209-45-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,2,0 and 9 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 13209-45:
(7*1)+(6*3)+(5*2)+(4*0)+(3*9)+(2*4)+(1*5)=75
75 % 10 = 5
So 13209-45-5 is a valid CAS Registry Number.

InChI:InChI=1/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h2,4,10,13-16H,3,5-9H2,1H3/t13-,14+,15+,16-,18-/m0/s1

13209-45-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name	(8R,9S,10R,13S,14S)-13-methyl-1,2,8,9,10,11,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,17-dione

1.2 Other means of identification

Product number	-
Other names	3,17-Dioxo-19-norandrosta-4,6-dien

1.3 Recommended use of the chemical and restrictions on use

Identified uses	For industry use only.
Uses advised against	no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number	-
Service hours	Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:13209-45-5 SDS

13209-45-5Upstream product

• 14907-40-5 3,17-Dioxo-10β-acetoxy-Δ^4,6-19-nor-androstadien 
• 14507-60-9 3,17-dioxoandrosta-4,6-dien-19-oic acid 
• 14507-55-2 19-hydroxyandrost-4,6-diene-3,17-dione 
• 6925-84-4 3-Ethoxy-17β-acetoxy-19-nor-androsta-3,5-dien 
• 2590-41-2 6-dehydro-19-nortestosterone acetate 
• 1425-10-1 19-nortestosterone acetate 
• 434-22-0 19-nortestosterone 
• 14531-84-1 17β-hydroxyestra-4,6-dien-3-one 
• 734-32-7 estra-4-ene-3,17-dione 

13209-45-5Downstream Products

• 17000-78-1 7α-Methyl-estr-4-ene-3,17-dione 
• 336786-05-1 7α-phenyl-estr-4-ene-3,17-dione 
• 17253-36-0 3-O-methyl-estra-1,3,5⁽¹⁰⁾,6-tetraen-17-one 
• 2208-12-0 6-dehydroestrone 

13209-45-5Relevant articles and documents

-

Zderic,J.A. et al.

, p. 233 - 249 (1963)

-

Synthesis of 3-methoxyestra-1,3,5(10),6-tetraen-17-one

Brosa,Ferrer,Malet,Amezaga

, p. 3984 - 3985 (1989)

-

Inhibitors of type 5 and type 3 17β-hydroxysteroid dehydrogenase and methods for their use

-

, (2008/06/13)

Novel methods of medical treatment and/or inhibition of development of diseases are disclosed for diseases that are sensitive to androgenic or estrogenic activity. The treatments utilize inhibitors of type 5 and/or type 3 17β-hydroxysteroid dehydrogenase. Novel inhibitors of type 5 17β-hydroxysteroid dehydrogenase are also disclosed, as are novel inhibitors of type 3 17β-hydroxysteroid dehydrogenase.

Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use

-

, (2008/06/13)

Novel anti-estrogenic compounds are provided which are useful to treat a variety of disorders, particularly estrogen-dependent disorders. Preferred compounds have a 1,3,5(10)-estratriene nucleus, and are substituted at the C-17 or C-11 position with a molecular moiety which renders the compounds effective to competitively block the binding of estrogen to its receptor. Particularly preferred compounds are 17-desoxy-1,3,5(10)-estratrienes. Therapeutic methods and pharmaceutical compositions are provided as well.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Please select Metric Ton KG G Pound L ML

Email:

Company name:

Valid Period:

Detailed Requirements:

• Sample
• MOQ
• GMP
• FDA
• Price
• Urgent purchase

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

Remove

Submit

1

What can I do for you?
Get Best Price

Get Best Price for 13209-45-5 4,6-estradiene-3,17-dione

Send

Send

Metric Ton KG G Pound L ML

Send

Send